Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HES 200/0.5 vs Ringer's Lactate in Severe Burn Injury
NCT01120730Phase 3Completed
- Sponsor
- University of Zurich
- Start
- Apr 1997
- Primary completion
- Sep 1998
- Modality
- Polymer-based Nanoparticles, Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hetastarch in burn injury, sponsored by University of Zurich. Started Apr 1997; status: completed.
02
Drugs
hetastarch
03
Conditions
burn injury
Beyond the preview
Go deeper on NCT01120730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01120730.